Product Information

PANTOPRAZOLE DR 40 MG SUSP PKT is a generic product labeled by Cipla USA Inc., priced at $3.1083 per EA under NDC 69097053153. Its NADAC has been published 67 times since Aug 6, 2025.

FDA first approved this application on Mar 31, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PANTOPRAZOLE DR 40 MG SUSP PKT

pantoprazole sodium granules
$3.1083per EA

Strength

40 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097053153

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PANTOPRAZOLE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA217458

FDA Approved

3/31/2025

TE Code

AB

On Market Since

4/3/2025

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has been published 67 times since Aug 6, 2025, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.

Current price$3.1083 per EA
All-time high$6.4752 (Aug 13, 2025)
All-time low$3.1083 (Oct 21, 2026)
52-week high$4.5960
52-week low$3.1083
Median price$4.3715
Average price$4.5081
Largest weekly change-19.2% (Oct 21, 2026)
Weeks tracked67
Tracking sinceAug 6, 2025

Price History

1W

0.0%

1M

-19.2%

3M

-32.4%

6M

-22.8%

1Y

-34.5%

3Y

N/A

5Y

N/A

All

-52.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pantoprazole sodium granules market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PANTOPRAZOLE DR 40 MG SUSP PKT?

The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE DR 40 MG SUSP PKT, manufactured by Cipla USA Inc., is $3.1083 per EA (NDC 69097053153), effective Nov 11, 2026.

How has the price of PANTOPRAZOLE DR 40 MG SUSP PKT changed over time?

Over the history we have for it, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has declined 52.0%. It has been tracked across 67 weekly CMS publications since Aug 6, 2025.

What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE DR 40 MG SUSP PKT?

Since Aug 6, 2025, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has ranged from a low of $3.1083 (Oct 21, 2026) to a high of $6.4752 (Aug 13, 2025), with a median of $4.3715 per EA.

Are there cheaper alternatives to PANTOPRAZOLE DR 40 MG SUSP PKT?

No other NADAC-published product currently shares the active ingredient and strength of PANTOPRAZOLE DR 40 MG SUSP PKT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PANTOPRAZOLE DR 40 MG SUSP PKT?

PANTOPRAZOLE DR 40 MG SUSP PKT (NDC 69097053153) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.